Paige vs Lunit
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Paige
The first FDA-authorized AI in pathology — built on 7M+ annotated slid...
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and lung cancer screening
Visit
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 6.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Enterprise |
| Free tier | Virchow & PRISM foundation models free on Hugging Face (research use; Apache 2.0 / CC-BY-NC-ND) | — |
| Paid from | Enterprise licensing — custom quote from Tempus/Paige; also on Azure Marketplace | — |
| Has API | ✓ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | In clinical use at hospitals and labs worldwide; training data spans 800+ labs across 45 countries | — |
| Founded | 2017 | 2013 |
| Maker | Tempus AI | — |
| Verdict | Paige is the standard-bearer for clinical AI in digital pathology — the only product holding FDA De Novo authorization for primary cancer diagnosis in pathology, now backed by Tempus AI's oncology data engine. Its clinic... |
Lunit is the most clinically validated medical-AI company to come out of Korea, and one of the few in the category with real revenue rather than just pilot deployments — Q1 2026 revenue hit 24 billion won, up nearly 25%... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.